Welcome to our dedicated page for C3.Ai news (Ticker: AI), a resource for investors and traders seeking the latest updates and insights on C3.Ai stock.
C3.ai, Inc. develops enterprise artificial intelligence application software for organizations deploying AI across large data environments. Company news centers on the C3 Agentic AI Platform, C3 AI Applications, C3 Generative AI, and C3 Code, along with SaaS revenue trends, product availability, and customer deployments in government, defense, energy, manufacturing, life sciences, and other enterprise markets.
Recurring updates also cover strategic integrator relationships, public-sector authorizations such as FedRAMP, AI logistics and field-service applications, customer agreements, quarterly results, and investor conference participation. These developments reflect the company’s focus on governed, domain-specific AI applications built for enterprise and government use cases.
C3 AI (NYSE:AI) reported preliminary Q4 2026 revenue of $51.6 million, within guidance, and a non-GAAP operating loss of $(54.4) million, better than guidance. GAAP operating loss was $(121.2) million.
Full-year 2026 revenue was $250.3 million, with GAAP and non-GAAP operating losses of $(498.5) million and $(217.8) million, respectively. Cash, cash equivalents, and investments totaled $575.4 million. Founder Thomas M. Siebel resumed the CEO role on May 8, 2026, while Stephen Ehikian continues as President. A restructuring plan targets about $135 million in annualized non-GAAP cost savings.
C3 AI (NYSE: AI) announced general availability of C3 Code on April 8, 2026, an enterprise AI development platform that converts natural-language prompts into governed, production-grade applications.
C3 Code features 40+ prebuilt industry packages, a unified type system, validated domain AI models, full-stack app generation, parallel agent orchestration, and LLM-agnostic portability. An external evaluation scored C3 Code 9.2/10 overall with a perfect 10 for Domain Intelligence.
C3 AI (NYSE: AI) will present at two investor conferences on March 2, 2026 in San Francisco.
CEO Stephen Ehikian will appear in fireside chats at The Citizens Technology Conference at 9:00 am PT and the Morgan Stanley TMT Conference at 10:00 am PT. Replays will be available on the company investor relations website.
C3 AI (NYSE: AI) reported fiscal Q3 2026 results: total revenue $53.3M, subscription revenue $48.2M (90% of revenue), GAAP gross profit $9.2M (17% margin) and non-GAAP gross profit $19.6M (37% margin). GAAP net loss per share was $(0.94); non-GAAP net loss per share was $(0.40). Cash and marketable securities were $621.9M.
The company closed 44 agreements, saw federal/defense bookings rise 134% YoY, and launched a restructuring expected to save about $135M annually. Q4 revenue guidance is $48.0–$52.0M and full-year revenue guidance is $246.7–$250.7M.
C3 AI (NYSE: AI) will release financial results for its fiscal third quarter ended January 31, 2026 after U.S. market close on Wednesday, February 25, 2026. A live conference call and webcast begin at 2:00 p.m. PST / 5:00 p.m. EST that day.
Analysts and investors may register for dial-in or webcast access; an audio replay will be posted about two hours after the call and remain available for 30 days on the C3 AI Investor Relations events page.
C3 AI (NYSE: AI) and Vonage (part of Ericsson, NASDAQ: ERIC) announced a strategic collaboration to launch C3 AI Field Services, an AI-first module integrated with Vonage Communications and Network APIs including Quality on Demand and Verify.
The solution targets mission-critical mobile field operations with agentic AI, voice/video remote assistance, knowledge management, and network-aware connectivity; demos available and showcases planned at MWC Barcelona (March 2–5, 2026) and C3 Transform (March 3–5, 2026).
C3 AI (NYSE: AI) achieved FedRAMP Moderate authorization, enabling U.S. federal agencies to adopt its C3 Agentic AI Platform for sensitive, data‑heavy workloads with federal‑grade security.
The designation adds to C3 AI’s existing IL5 and IL6 authorizations, lists the company on the FedRAMP Marketplace, and is presented as accelerating federal adoption of the company’s Enterprise AI capabilities for mission‑critical programs.
C3 AI (NYSE: AI) was named a Leader in Enterprise AI platforms by Verdantix after evaluation of eleven vendors on December 10, 2025. Verdantix awarded C3 AI the highest score across multiple categories including AI technical depth, data source orchestration, unstructured data utilization, model training and fine-tuning, dashboard builder, cybersecurity and model guardrails, and deployment options.
CEO Stephen Ehikian noted the company has used the C3 Agentic AI Platform to develop over 130 turnkey Enterprise AI applications and stated customers have realized economic benefit “exceeding billions of dollars per year.”
C3 AI (NYSE: AI) was selected by the U.S. Army Rapid Capabilities and Critical Technologies Office on December 9, 2025 to deliver an AI contested logistics solution for combat operations.
The company will integrate AI-driven forecasting for parts, fuel, and munitions into a Brigade Command & Control network to support re-supply and distribution in contested environments, bolster combat readiness, and maintain operational tempo. The work leverages components of C3 AI Contested Logistics and C3 AI Readiness already operational at the Defense Logistics Agency and U.S. Air Force.
C3 AI (NYSE: AI) announced on December 4, 2025 that the U.S. Department of Health and Human Services selected the C3 Agentic AI Platform to create a unified, secure, and scalable data foundation across the National Institutes of Health and the Centers for Medicare & Medicaid Services.
The platform will integrate NIH disease-specific data enclaves with Medicare, Medicaid, claims, and state registry datasets to improve data quality, governance, research, analytics, and applications while enforcing strict privacy and security requirements. HHS will also use the platform to automate complex administrative workflows to support biomedical research, program integrity, and public health analysis.